Journal of substance abuse treatment
Journal
Overview
publication venue for
-
Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid use disorder before release from prison versus after release..
141.
2022
-
Research to law: A qualitative study of Massachusetts' 2018 Care Act expanding emergency department initiation of medication for opioid use disorder..
141.
2022
-
Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder.
2022
-
The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail..
128.
2021
-
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)..
128.
2021
-
Health economic analyses of the justice community opioid innovation network (JCOIN)..
128.
2021
-
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail..
128.
2020
-
Healthcare utilization patterns among persons who use drugs during the COVID-19 pandemic..
121.
2020
-
Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future..
112S.
2020
-
Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings..
110.
2019
-
Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City..
106.
2019
-
Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events?.
105.
2019
-
The association between county-level safety net treatment access and opioid hospitalizations and mortality in New York..
100.
2019
-
Establishing the feasibility, acceptability and preliminary efficacy of a multi-component behavioral intervention to reduce pain and substance use and improve physical performance in older persons living with HIV..
100.
2019
-
Re-engineering methadone-Cost-effectiveness analysis of a patient-centered approach to methadone treatment..
94.
2018
-
Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision..
81.
2017
-
Monetary conversion factors for economic evaluations of substance use disorders..
81.
2017
-
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population..
85.
2017
-
Hepatitis C virus core antigen: A potential alternative to HCV RNA testing among persons with substance use disorders..
78.
2017
-
Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?.
85.
2017
-
READY or Not: Findings From a School-Based MI Intervention for Adolescent Substance Use..
71.
2016
-
Examining Longitudinal Stimulant Use and Treatment Attendance as Parallel Outcomes in Two Contingency Management Randomized Clinical Trials..
61.
2015
-
Determinants of buprenorphine treatment for opioid dependence..
46.
2013
-
Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States..
42.
2011
-
Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network..
30.
2006
-
Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance..
30.
2006
-
Quality of life as an outcome of opioid use disorder treatment: A systematic review.
2017
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)